ABVC BIOPHARMA, INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q4 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Abvc Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2010 to Q1 2024.
  • Abvc Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $676K, a 69.4% decline year-over-year.
  • Abvc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.92M, a 2.37% decline from 2022.
  • Abvc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.01M, a 59.8% decline from 2021.
  • Abvc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $10M, a 4.47% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $676K -$1.53M -69.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q1 2023 $2.21M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q1 2021 $42.2K -$568K -93.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $610K -$763K -55.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $1.37M +$1.02M +293% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q1 2018 $350K -$600K -63.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-28
Q1 2017 $950K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2014 $0 $0 Oct 1, 2014 Dec 31, 2014 10-Q 2015-04-17
Q4 2013 $0 -$25K -100% Oct 1, 2013 Dec 31, 2013 10-Q 2015-04-17
Q4 2012 $25K -$318K -92.7% Oct 1, 2012 Dec 31, 2012 10-Q 2015-04-17
Q4 2011 $343K +$171K +99.5% Oct 1, 2011 Dec 31, 2011 10-Q 2015-04-16
Q4 2010 $172K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.